• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number EVD35-06-100-120
Device Problems Fracture (1260); Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/05/2024
Event Type  Injury  
Event Description
Physician was attempting to use an everflex entrust self-expanding stent along with a 45cm 5fr sheath during treatment of a plaque lesion in the patients right mid distal superficial femoral artery (sfa).No vessel tortuosity and moderate vessel calcification were reported.There were no abnormalities reported in relation to anatomy.Embolic protection was not used.There was no damage noted to packaging (i.E.Shelf carton, hoop/tray).There were no issues noted when removing the device from the hoop/tray.The device was prepped per the ifu with no issues identified.A 4mm evercross balloon was used for pre-dilation.The device did not pass through a previously-deployed stent.No resistance was encountered when advancing the device.The surgeon placed the stent over wire and to the target lesion area and pulled the red locking pin off the device.The surgeon began to deploy the stent by using the rotating thumb wheel and the stent began to deploy and stopped deploying mid-way.The rotating thumb wheel would not move and was stuck.The stent was only half deployed, so the surgeon broke the handle into 2 pieces, once the handle was broken, parts of the red locking pin were visible inside the stent tri-axial system.The surgeon used a hemostat to remove remaining red locking pieces.The surgeon pulled the string and the string broke.The stent was still only half deployed, so the surgeon used a scalpel to break apart tri-axial system.Once the surgeon dissected the device down past the blue sheath the stent finally finished deploying.Stent was deployed at the target lesion.The stent appeared to be elongated and possibly fractured once deployed on the live fluoroscopy image.Surgeon decided to re-align the stent with a new stent.Lesion was then open and image appeared normal.No patient injury reported.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Product analysis #706237378:analysis the device was returned dismantled with damage noted to different parts of the device, most notably; the pull cable was still attached to the deployment wheel but not to the rest of the device.The red locking pin was damaged, and the lock tube had broken, also there were parts of the silver sheath cut and separate to the device, the device was identified by the strain relief, a kink and a series of what appeared like ¿chatter marks¿ were observed on the gold inner sheath from approx.12cm to 15cm from the back luer, the silver sheath was observed damaged and cut at the distal end of the blue outer sheath the red lock pin, red lock tube, a section of gold inner sheath with red lock tubing attached to it and cut pieces of silver sheath were also returned out of the device and with damage, the red lock pin was observed with a small piece of red lock tube protruding for the pin at the point of the break, medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18798621
MDR Text Key336456188
Report Number2183870-2024-00068
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEVD35-06-100-120
Device Lot NumberB636938
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/06/2024
Initial Date FDA Received02/28/2024
Supplement Dates Manufacturer Received04/25/2024
04/25/2024
Supplement Dates FDA Received04/26/2024
04/26/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/09/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-1644-2022
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-